Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Uveal Melanoma 1Radiation Injuries 1Prostatic Diseases 1Melanoma 1Locally Advanced Cervical Carcinoma 1Glioblastoma 1Cervical Adenocarcinoma 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Trastuzumab 62Paclitaxel 57Cyclophosphamide 44pembrolizumab 34Fulvestrant 34Capecitabine 29Carboplatin 26Docetaxel 23Letrozole 22Doxorubicin 19palbociclib 16abemaciclib 16pertuzumab 15durvalumab 14Filgrastim 13Everolimus 13ribociclib 12Lapatinib 12Gemcitabine 12exemestane 11eribulin 11Vinorelbine 11Albumin-Bound Paclitaxel 11Bevacizumab 10trastuzumab deruxtecan 9neratinib 9fludarabine 9Taxes 9Radiotherapy 9Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Breast Neoplasms × Brachytherapy × Clear all
NCT00002873 2013-07-19

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

Radiation Therapy Oncology Group

Phase 1/2 Completed
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡